ApoE Promotes the Proteolytic Degradation of Aβ

Jiang, Qingguang, Lee, C.Y. Daniel, Mandrekar, Shweta, Wilkinson, Brandy, Cramer, Paige, Zelcer, Noam, Mann, Karen, Lamb, Bruce +9 more·2008·Neuron

DOI 10.1016/j.neuron.2008.04.010

Cited by (876)

Items 201–300 of 876

ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain
YuHong Fu, Jen-Hsiang T. Hsiao, George Paxinos, Glenda Margaret Halliday, Woojin Scott Kim · 2016 · Journal of Alzheimer s Disease
Inflammation in transgenic mouse models of neurodegenerative disorders
Schwab, Claudia, Klegeris, Andis, McGeer, Patrick. L. · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Greasing the wheels of Aβ clearance in Alzheimer's Disease: The role of lipids and apolipoprotein E
Fan, Jianjia, Donkin, James, Wellington, Cheryl · 2009 · BioFactors
Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation
Sun Haeng Park, Ji Hyun Kim, Sun Sik Bae, Ki Whan Hong, Dong‐Seok Lee, Jae Yoon Leem, Byung Tae Choi, Hwa Kyoung Shin · 2011 · Biochemical and Biophysical Research Communications
The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
S. Mulder, R. Veerhuis, M. Blankenstein, H. Nielsen · 2012 · Experimental Neurology
Apolipoprotein E receptors in the nervous system
Joachim Herz · 2009 · Current Opinion in Lipidology
Genetics of Alzheimer’s Disease
Perry G. Ridge, Mark Ebbert, John S. K. Kauwe · 2013 · BioMed Research International
Nuclear receptors in neurodegenerative diseases
Skerrett, Rebecca, Malm, Tarja, Landreth, Gary · 2014 · Neurobiology of Disease
Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer’s Disease Prevention and Early Intervention
Keeney, Jeriel Thomas-Richard, Ibrahimi, Shaher, Zhao, Liqin · 2015 · Journal of Alzheimer's Disease
Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors
Kang, Jihong, Rivest, Serge · 2012 · Endocrine Reviews
Amyloid-β Pathology and APOE Genotype Modulate Retinoid X Receptor Agonist Activity in Vivo
Leon M. Tai, Kevin P. Koster, Jia Luo, Sue Lee, Yue‐ting Wang, Nicole C. Collins, Manel Ben Aissa, Gregory R. J. Thatcher, Mary Jo LaDu · 2014 · Journal of Biological Chemistry
Genetics and genomics of human ageing
Heather E. Wheeler, Stuart K. Kim · 2010 · Philosophical Transactions of the Royal Society B Biological Sciences
ABC Transporters Are Key Players in Alzheimer’s Disease
Cátia D. Pereira, Filipa Martins, Jens Wiltfang, Odete A. B. da Cruz e Silva, Sandra Rebelo · 2017 · Journal of Alzheimer s Disease
Apolipoprotein E in Alzheimer’s disease: molecular insights and therapeutic opportunities
Belaidi, Abdel Ali, Bush, Ashley I., Ayton, Scott · 2025 · Molecular Neurodegeneration
Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update
Mahmood Ahmad Khan, Qamre Alam, Absarul Haque, Mohammad Ashafaq, Mohd Jahir Khan, Ghulam Md Ashraf, Mahboob Ahmad · 2018 · Current Neuropharmacology
Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer’s disease mouse model
Jeroen F. J. Bogie, Cindy Hoeks, Melissa Schepers, Assia Tiane, Ann Cuypers, Frank P. J. Leijten, Yupyn Chintapakorn, Thiti Suttiyut, Surachai Pornpakakul, Dicky Struik et al. · 2019 · Scientific Reports
The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer’s disease
Su, Qiang, Guo, Jun-Hong, Zhang, Yan-Li, Wang, Juan, Zhang, Zhi-Na · 2022 · Neural Regeneration Research
Retinoids as potential targets for Alzheimer's disease
Rupinder Kaur Sodhi, Nirmal Singh · 2014 · Pharmacology Biochemistry and Behavior
SUMO and Alzheimer’s Disease
Linda Lee, Mikako Sakurai, Shinsuke Matsuzaki, Ottavio Arancio, Paul E. Fraser · 2013 · NeuroMolecular Medicine
Effect of Cholesterol on Membrane Fluidity and Association of Aβ Oligomers and Subsequent Neuronal Damage: A Double-Edged Sword
Eduardo J. Fernández-Pérez, Fernando J. Sepúlveda, Christian Peters, Denisse Bascuñán, Nicolás Riffo-Lepe, Juliana González-Sanmiguel, Susana A. Sánchez, Robert W. Peoples, Benjamín Vicente, Luis Gerardo Aguayo · 2018 · Frontiers in Aging Neuroscience
Aβ Internalization by Neurons and Glia
Amany Mohamed, E Chaves · 2011 · International Journal of Alzheimer s Disease
Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration
Kuszczyk, Magdalena A., Sanchez, Sandrine, Pankiewicz, Joanna, Kim, Jungsu, Duszczyk, Malgorzata, Guridi, Maitea, Asuni, Ayodeji A., Sullivan, Patrick M., Holtzman, David M., Sadowski, Martin J. · 2013 · The American Journal of Pathology
Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice
Rebecca Skerrett, Mateus Paquesse Pellegrino, Brad T. Casali, Laura Taraboanta, Gary E. Landreth · 2015 · Journal of Biological Chemistry
Lipoproteins in the Central Nervous System: From Biology to Pathobiology
Raulin, Ana-Caroline, Martens, Yuka A., Bu, Guojun · 2022 · Annual Review of Biochemistry
Restored degradation of the Alzheimer’s amyloid‐β peptide by targeting amyloid formation
Peter John Crouch, Deborah J. Tew, Tai Du, Diem Nguyen, Aphrodite Caragounis, Gulay Filiz, Rachel E. Blake, Ian Andrew Trounce, Cynthia P.W. Soon, Katrina M. Laughton et al. · 2009 · Journal of Neurochemistry
Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer’s Disease Biology: Characterization of Putative Cognates for Therapeutic Applications
N. K. Jha, S. Jha, Dhiraj Kumar, Noopur Kejriwal, Renubala Sharma, R. K. Ambasta, Pravir Kumar · 2015 · Journal of Alzheimer's Disease
The role of glycogen synthase kinase 3 in the early stages of Alzheimers’ disease
Félix Hernández, Jesús Ávila · 2008 · FEBS Letters
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B
Yu Zhang, Benjamin Schmid, Nanett Kvist Nikolaisen, Mikkel A. Rasmussen, Blanca I. Aldana, Mikkel Pejstrup Agger, Kirstine Calløe, Tina C. Stummann, Hjalte M. Larsen, Troels T. Nielsen et al. · 2017 · Stem Cell Reports
Neuroprotective astrocyte-derived insulin/insulin-like growth factor 1 stimulates endocytic processing and extracellular release of neuron-bound Aβ oligomers
Jason E. Pitt, Kyle C. Wilcox, Vanessa Tortelli, Luan Pereira Diniz, Maira S. Oliveira, Cassandra Dobbins, Xiaowen Yu, Sathwik Nandamuri, Flávia Carvalho Alcântara Gomes, Nadia DiNunno et al. · 2017 · Molecular Biology of the Cell
The AβCs of Aβ-cleaving Proteases*
M. Leissring · 2008 · Journal of Biological Chemistry
Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs for the Prevention of Alzheimers Disease
Greg M. Cole, Sally Ann Frautschy · 2010 · CNS & Neurological Disorders - Drug Targets
Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice
LaClair, Katherine D, Manaye, Kebreten F, Lee, Dexter L, Allard, Joanne S, Savonenko, Alena V, Troncoso, Juan C, Wong, Philip C · 2013 · Molecular Neurodegeneration
Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
Robert A. Marr, Daniel M. Hafez · 2014 · Frontiers in Aging Neuroscience
ABC transporters: human disease and pharmacotherapeutic potential
Jonathan M. Moore, Eric L. Bell, Robert O Hughes, Alastair S. Garfield · 2022 · Trends in Molecular Medicine
Plant sterols: Friend or foe in CNS disorders?
T. Vanmierlo, J. Bogie, Jo Mailleux, J. Vanmol, D. Lütjohann, M. Mulder, Jerome J. A. Hendriks · 2015 · Progress in lipid research
Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Waqar Ahmad · 2012 · Molecular Neurobiology
The Complex Role of Apolipoprotein E in Alzheimer’s Disease: an Overview and Update
Laura Mahoney‐Sanchez, Abdel Ali Belaidi, Ashley Ian Bush, Scott Ayton · 2016 · Journal of Molecular Neuroscience
Amyloid β inhibits retinoic acid synthesis exacerbating A lzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist
Maria Beatriz C.V. Goncalves, Earl E. Clarke, Carl Hobbs, Tony Malmqvist, Robert M. J. Deacon, Julian Jack, Jonathan P. T. Corcoran · 2013 · European Journal of Neuroscience
Apolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade
Huntington Potter, Thomas Wısnıewskı · 2012 · International Journal of Alzheimer s Disease
APOE effects on regional tau in preclinical Alzheimer’s disease
Young, Christina B., Johns, Emily, Kennedy, Gabriel, Belloy, Michael E., Insel, Philip S., Greicius, Michael D., Sperling, Reisa A., Johnson, Keith A., Poston, Kathleen L., Mormino, Elizabeth C. et al. · 2023 · Molecular Neurodegeneration
APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease
Yen Ying Lim, Victor L. Villemagne, Robert H. Pietrzak, David J. Ames, Kathryn A. Ellis, Karra Harrington, Peter Jeffrey Snyder, Ralph Nigel Martins, Colin Louis Masters, Christopher C. Rowe et al. · 2014 · Neurobiology of Aging
The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases
Walter, Jochen · 2016 · Journal of Biological Chemistry
Lipid Metabolism and Glial Lipoproteins in the Central Nervous System
Hayashi, Hideki · 2011 · Biological and Pharmaceutical Bulletin
DNA methylation alterations in Alzheimer’s disease
Amy S. Yokoyama, John C. Rutledge, Valentina Medici · 2017 · Current Zoology
Deciphering cell–cell communication at single-cell resolution for spatial transcriptomics with subgraph-based graph attention network
Wenyi Yang, Pingping Wang, Shouping Xu, Tao Wang, Meng Luo, Yideng Cai, Chang Xu, Guangfu Xue, Jinhao Que, Qian Ding et al. · 2024 · Nature Communications
Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions
Min‐Young Noh, Hyuk Sung Kwon, Min‐Soo Kwon, Minyeop Nahm, Hee Kyung Jin, Jae‐sung Bae, Seung Hyun Kim · 2025 · Molecular Neurodegeneration
Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer’s pathology: Insights and therapeutic approaches from periphery
Ullah, Rahat, Park, Tae Ju, Huang, Xu, Kim, Myeong Ok · 2021 · Ageing Research Reviews
Magnolol alleviates Alzheimer's disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ
Zhishen Xie, Jianping Zhao, Hui Wang, Yali Jiang, Qiaoling Yang, Yu Fu, Huahui Zeng, Christian Hölscher, Jiangyan Xu, Zhenqiang Zhang · 2020 · Biomedicine & Pharmacotherapy
Towards Understanding the Roles of Heparan Sulfate Proteoglycans in Alzheimer’s Disease
Gan-lin Zhang, Xiao Zhang, Xiaomin Wang, Jin‐Ping Li · 2014 · BioMed Research International
Remembering your A, B, C's: Alzheimer's disease and ABCA1
Lewandowski, Cutler T., Laham, Megan S., Thatcher, Gregory R.J. · 2022 · Acta Pharmaceutica Sinica B
Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)
Gary D. Probst, Ying‐zi Xu · 2012 · Expert Opinion on Therapeutic Patents
Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration
van Dijk, Gertjan, van Heijningen, Steffen, Reijne, Aaffien C., Nyakas, Csaba, van der Zee, Eddy A., Eisel, Ulrich L. M. · 2015 · Frontiers in Neuroscience
Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals
Rasmussen, Katrine L., Tybjærg‐Hansen, Anne, Nordestgaard, Børge G., Frikke‐Schmidt, Ruth · 2018 · Alzheimer's & Dementia
Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan
Halford, Rebekkah W., Russell, David W. · 2009 · Proceedings of the National Academy of Sciences
Protective Effects of Anthocyanins against Amyloid β-Peptide-Induced Damage in Neuro-2A Cells
Ping‐Hsiao Shih, Chih‐Hsiung Wu, Chi‐Tai Yeh, Gow‐Chin Yen · 2011 · Journal of Agricultural and Food Chemistry
Loss of Interleukin Receptor-Associated Kinase 4 Signaling Suppresses Amyloid Pathology and Alters Microglial Phenotype in a Mouse Model of Alzheimer's Disease
Brent Cameron, Wayne Tse, Raza Lamb, Xiaoxia Li, Bruce T. Lamb, Gary E. Landreth · 2012 · Journal of Neuroscience
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease
Miguel Moutinho, Gary E. Landreth · 2017 · Journal of Lipid Research
Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer’s Disease
Manoj Govindarajulu, Priyanka D. Pinky, Jenna Bloemer, Nila Ghanei, Vishnu D. Suppiramaniam, Rajesh Amin · 2018 · PPAR Research
Rodent Models of Amyloid-Beta Feature of Alzheimer’s Disease: Development and Potential Treatment Implications
Chi Him Poon, Yingyi Wang, Man‐Lung Fung, Chengfei Zhang, Lee Wei Lim · 2020 · Aging and Disease
Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid
Heinsinger, Nicolette Mary, Gachechiladze, Mariam Alexandra, Rebeck, G. William · 2016 · Journal of Neuropathology & Experimental Neurology
Response to Comments on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”
Gary E. Landreth, Paige E. Cramer, Mitchell M. Lakner, John R. Cirrito, Daniel W. Wesson, Kurt R. Brunden, Donald A. Wilson · 2013 · Science
Apolipoprotein E associated with reconstituted high‐density lipoprotein‐like particles is protected from aggregation
Hubin, Ellen, Verghese, Philip B., van Nuland, Nico, Broersen, Kerensa · 2019 · FEBS Letters
Shifting equilibriums in Alzheimer’s disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesis
Sophie Gray, K. J. Kinghorn, Nathaniel S. Woodling · 2020 · Neural Regeneration Research
Preparation of fluorescently‐labeled amyloid‐beta peptide assemblies: the effect of fluorophore conjugation on structure and function
Lisa M. Jungbauer, Chunjiang Yu, Kevin Laxton, Mary Jo LaDu · 2009 · Journal of Molecular Recognition
Frontiers in therapeutic development of allopregnanolone for Alzheimer’s disease and other neurological disorders
Ronald W. Irwin, Christine M. Solinsky, Roberta Dı́az Brinton · 2014 · Frontiers in Cellular Neuroscience
Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease
Cezary Żekanowski, Urszula Wojda · 2009 · Acta Neurobiologiae Experimentalis
A randomized controlled study to evaluate the effect of bexarotene on amyloid‐β and apolipoprotein E metabolism in healthy subjects
Ghosal, Kaushik, Haag, Michael, Verghese, Philip B., West, Tim, Veenstra, Tim, Braunstein, Joel B., Bateman, Randall J., Holtzman, David M., Landreth, Gary E. · 2016 · Alzheimer's & Dementia: Translational Research & Clinical Interventions
Disrupted functional and structural networks in cognitively normal elderly subjects with the APOE ɛ4 allele
Chen, Yaojing, Chen, Kewei, Zhang, Junying, Li, Xin, Shu, Ni, Wang, Jun, Zhang, Zhanjun, Reiman, Eric M · 2015 · Neuropsychopharmacology
ACAT inhibition and amyloid beta reduction
Raja Bhattacharyya, Dora M. Kovacs · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
CSF Apo-E levels associate with cognitive decline and MRI changes
For the Alzheimer’s Disease Neuroimaging Initiative, Toledo, Jon B., Da, Xiao, Weiner, Michael W., Wolk, David A., Xie, Sharon X., Arnold, Steven E., Davatzikos, Christos, Shaw, Leslie M., Trojanowski, John Q. · 2014 · Acta Neuropathologica
Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation
M. Shinohara, R. Petersen, D. Dickson, Guo-Jun Bu · 2013 · Acta Neuropathologica
Dissecting the Gene Dose-Effects of the APOE ε4 and ε2 Alleles on Hippocampal Volumes in Aging and Alzheimer’s Disease
Christopher A. Hostage, Kingshuk Roy Choudhury, Pudugramam Murali Doraiswamy, Jeffrey R. Petrella, Alzheimer’s Disease Neuroimaging Initiative · 2013 · PLoS ONE
Lipoprotein Lipase Is a Novel Amyloid β (Aβ)-binding Protein That Promotes Glycosaminoglycan-dependent Cellular Uptake of Aβ in Astrocytes
Kazuchika Nishitsuji, Takashi Hosono, Kenji Uchimura, Makoto Michikawa · 2010 · Journal of Biological Chemistry
The VCAM1–ApoE pathway directs microglial chemotaxis and alleviates Alzheimer’s disease pathology
Lau, Shun-Fat, Wu, Wei, Wong, Hiu Yi, Ouyang, Li, Qiao, Yi, Xu, Jiahui, Lau, Jessica Hiu-Yan, Wong, Carlton, Jiang, Yuanbing, Holtzman, David M. et al. · 2023 · Nature Aging
Apolipoprotein E3 (ApoE3) but Not ApoE4 Protects against Synaptic Loss through Increased Expression of Protein Kinase Cϵ
Abhik Sen, Daniel L. Alkon, Thomas J. Nelson · 2012 · Journal of Biological Chemistry
Cellular Source of Apolipoprotein E4 Determines Neuronal Susceptibility to Excitotoxic Injury in Transgenic Mice
Buttini, Manuel, Masliah, Eliezer, Yu, Gui-Qiu, Palop, Jorge J., Chang, Shengjun, Bernardo, Aubrey, Lin, Carol, Wyss-Coray, Tony, Huang, Yadong, Mucke, Lennart · 2010 · The American Journal of Pathology
Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How
Lewandowski, Cutler T., Maldonado Weng, Juan, LaDu, Mary Jo · 2020 · Neurobiology of Disease
Peptides as Potential Therapeutics for Alzheimer’s Disease
Samo Ribarič · 2018 · Molecules
Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
Brown, Madeleine R., Radford, Sheena E., Hewitt, Eric W. · 2020 · Frontiers in Molecular Neuroscience
Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
Zhuohang Liu, Hang Li, Shuyi Pan · 2021 · Frontiers in Genetics
Reduced amyloid‐β degradation in early A lzheimer's disease but not in the APP swe PS 1dE9 and 3x T g‐ AD mouse models
Anita Stargardt, Judith Gillis, Willem Kamphuis, Anne Wiemhoefer, Lieneke Kooijman, Marcel A. Raspe, Willemien E. Benckhuijsen, Jan Wouter Drijfhout, Elly M. Hol, Eric A. Reits · 2013 · Aging Cell
Transcriptional regulation and its misregulation in Alzheimer’s disease
Xiao‐Fen Chen, Yun‐wu Zhang, Huaxi Xu, Guojun Bu · 2013 · Molecular Brain
Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets
Han, Sun-Ho, Park, Jong-Chan, Mook-Jung, Inhee · 2016 · Progress in Neurobiology
Alzheimer’s Disease Risk Genes and Lipid Regulators
Farida El Gaamouch, Ping Jing, Jiahong Xia, Dongming Cai · 2016 · Journal of Alzheimer s Disease
ApoE Regulates the Development of Adult Newborn Hippocampal Neurons
Yacine Tensaouti, Elizabeth P. Stephanz, Tzong‐Shiue Yu, Steven G. Kernie · 2018 · eNeuro
The NR4A orphan nuclear receptors mediate transcription-dependent hippocampal synaptic plasticity
Bridi, Morgan S., Abel, Ted · 2013 · Neurobiology of Learning and Memory
ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice
Angela W. Corona, Nathan Kodoma, Brad T. Casali, Gary E. Landreth · 2015 · Journal of Neuroimmune Pharmacology
Transcriptional Effects of ApoE4: Relevance to Alzheimer’s Disease
Theendakara, Veena, Peters-Libeu, Clare A., Bredesen, Dale E., Rao, Rammohan V. · 2018 · Molecular Neurobiology
Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity
Mounier, A., Georgiev, D., Nam, K. N., Fitz, N. F., Castranio, E. L., Wolfe, C. M., Cronican, A. A., Schug, J., Lefterov, I., Koldamova, R. · 2015 · Journal of Neuroscience
From Genetics to Neuroinflammation: The Impact of ApoE4 on Microglial Function in Alzheimer’s Disease
Daniela Dias, Camila Cabral Portugal, João Bettencourt Relvas, Renato Socodato · 2025 · Cells
Endogenous Sex Hormones and Cognitive Function in Older Adults
Lisa Boss, Duck-Hee Kang, Marianne T. Marcus, Nancy I. Bergstrom · 2013 · Western Journal of Nursing Research
Exploring glia to better understand Alzheimer’s disease
Yoo Sung Kim, Hae Myeong Jung, Bo‐Eun Yoon · 2018 · Animal Cells and Systems
Memory Deficits in APP23/ Abca1 +/− Mice Correlate with the Level of A β Oligomers
Iliya M. Lefterov, Nicholas Francis Fitz, Andrea A. Cronican, Preslav Lefterov, Matthias Staufenbiel, Radosveta P. Koldamova · 2009 · ASN NEURO
MyD88 Deficiency Ameliorates β-Amyloidosis in an Animal Model of Alzheimer's Disease
Lim, Jeong-Eun, Kou, Jinghong, Song, Min, Pattanayak, Abhinandan, Jin, Jingji, Lalonde, Robert, Fukuchi, Ken-ichiro · 2011 · The American Journal of Pathology
Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: Effect of coenzyme Q10 supplementation on these parameters
Nanna Cornelius, Jonathan Henry Wardman, Iain Parry Hargreaves, Viruna Neergheen, Anne Sigaard Bie, Zeynep Tümer, Jørgen Erik Nielsen, Troels T. Nielsen · 2017 · Mitochondrion
Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer’s disease and strategies for treatment
Chaves, Juliana C.S., Dando, Samantha J., White, Anthony R., Oikari, Lotta E. · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury
Cao, Jiqing, Gaamouch, Farida El, Meabon, James S., Meeker, Kole D., Zhu, Li, Zhong, Margaret B., Bendik, John, Elder, Gregory, Jing, Ping, Xia, Jiahong et al. · 2017 · Scientific Reports
Microglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
Brad T. Casali, Erin G. Reed-Geaghan · 2021 · Cells
Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease
Brad T. Casali, Angela W. Corona, Monica M. Mariani, J. Colleen Karlo, K. Ghosal, Gary E. Landreth · 2015 · Journal of Neuroscience
Anesthesia and the Old Brain
Junxia X. Tang, Maryellen Fazen Eckenhoff, Roderic G. Eckenhoff · 2010 · Anesthesia & Analgesia